Our Services
Medical Information
Helpful Resources
Published on: 9/24/2026
BlueChew's chewable ED tablets contain sildenafil, tadalafil, or vardenafil, and the most common side effects include headache, facial flushing, nasal congestion, indigestion or heartburn, dizziness, nausea, vision changes such as a blue tint or light sensitivity, and back or muscle aches more often linked to tadalafil. Rare but serious reactions include an erection lasting more than four hours, sudden vision or hearing loss, chest pain, fainting, and dangerous drops in blood pressure when combined with nitrates, alpha-blockers, or certain other medications. Dosage, underlying heart conditions, alcohol use, and which active ingredient you take all change your risk profile, so there are several important factors to consider before assuming a symptom is harmless. See below to understand more, including which effects typically fade and which ones warrant stopping the medication and calling a doctor.
Because ED side effects can overlap with signs of cardiovascular, hormonal, or neurological conditions, a free, instant, online symptom check can help you sort out whether what you are feeling is a predictable medication reaction or something that deserves a closer look, and it takes only a few minutes to get personalized guidance on your next steps.
Last reviewed for medical accuracy: 09/24/2026
BlueChew is a subscription-based service that delivers chewable tablets of sildenafil or tadalafil—two medications in the PDE5 inhibitor class frequently prescribed for erectile dysfunction (ED). By helping increase blood flow to the penis, these medicines can support better erections when sexually stimulated. While many users experience improved performance, it’s important to understand the potential bluechew side effects before starting treatment.
Both sildenafil and tadalafil block an enzyme called phosphodiesterase type 5 (PDE5), which normally breaks down a molecule (cGMP) that relaxes smooth muscle in blood vessels. By preventing cGMP’s breakdown, these drugs promote vasodilation (widening of blood vessels) in the penis, enabling easier blood flow.
Most side effects associated with BlueChew come from sildenafil or tadalafil’s mechanism of action. They’re usually mild to moderate and often resolve on their own within a few hours. Common bluechew side effects include:
Tips for managing mild side effects:
While rare, some side effects require immediate medical attention. If you experience any of the following, stop using BlueChew and seek emergency care:
Before starting BlueChew, make sure you discuss your full medical history with a healthcare provider. You should not take BlueChew if you:
BlueChew’s active ingredients can interact with other medications you’re taking. Common interactions include:
Always provide your prescribing doctor with a list of all prescription, over-the-counter, and herbal supplements you take. This helps prevent harmful interactions.
Even if you feel fine, regular check-ins with your healthcare provider are important:
Not sure if a symptom needs prompt attention? You might consider doing a free, online symptom check, using the doctor approved Ubie Symptom Checker to help figure out next steps.
For most men, the benefits of improved sexual function outweigh the mild, short-lived side effects of sildenafil or tadalafil. However, bluechew side effects can occasionally be severe. By staying informed and communicating openly with your doctor, you’ll be better positioned to:
Seek immediate medical care if you experience:
For less urgent concerns, reach out to your primary care doctor or urologist. If you’re unsure how serious your symptom is, you can always try a free, online symptom check, using the doctor approved Ubie Symptom Checker to help guide you.
BlueChew offers a convenient way to manage erectile dysfunction, but like all medications, it carries potential risks. Knowing the spectrum of bluechew side effects—from common headaches and flushing to rare but serious complications—empowers you to use these treatments safely and effectively.
Always discuss any new or worsening symptoms with a qualified medical professional. For concerns that might be life-threatening or severe, do not delay: seek emergency care or contact your doctor right away.
Speak to a doctor before making changes to your medication regimen or if you experience any alarming side effects. Your health and safety come first.
(References)
* Rosenberg KP. Sildenafil. J Sex Marital Ther. 1999 Oct-Dec;25(4):271-9. doi: 10.1080/00926239908404004. PMID: 10546165.
* Daghfous R, El Aidli S, Zaiem A, Loueslati MH, Belkahia C. Sildenafil-associated hepatotoxicity. Am J Gastroenterol. 2005 Aug;100(8):1895-6. doi: 10.1111/j.1572-0241.2005.41983_6.x. PMID: 16086731.
* Yamazaki Y, Yamada A, Sugaya S, Osawa A. [Visual disturbance]. Nihon Rinsho. 2012 Aug;70 Suppl 6:686-9. PMID: 23156598.
* Ashour AE, Rahman AF, Kassem MG. Vardenafil dihydrochloride. Profiles Drug Subst Excip Relat Methodol. 2014;39:515-44. doi: 10.1016/B978-0-12-800173-8.00009-X. PMID: 24794912.
* Molehin OR, Adeyanju AA, Adefegha SA, Aina OO, Afolabi BA, Olowoyeye AO, Oyediran JA, Oladiran OR. Sildenafil, a phosphodiesterase-5 inhibitor, offers protection against carbon tetrachloride-induced hepatotoxicity in rat. J Basic Clin Physiol Pharmacol. 2018 Jan 26;29(1):29-35. doi: 10.1515/jbcpp-2017-0011. PMID: 29283882.
* Tharwat M, Elsaadany MM, Lashin AM, El-Nahas AR. A randomized controlled trial evaluating sildenafil citrate in relieving ureteral stent-related symptoms. World J Urol. 2018 Nov;36(11):1877-1881. doi: 10.1007/s00345-018-2339-y. Epub 2018 May 15. PMID: 29766318.
* Kaku Y, Chiba K, Sato K, Onishi A, Ishida T, Okada K, Fujisawa M. Protective effects of tadalafil against cisplatin-induced spermatogenic dysfunction. Biochem Biophys Res Commun. 2022 May 7;603:123-129. doi: 10.1016/j.bbrc.2022.02.113. Epub 2022 Mar 6. PMID: 35287053.
* Phosphodiesterase-5 inhibitors for Alzheimer's disease? Med Lett Drugs Ther. 2022 Oct 31;64(1662):174-175. PMID: 36383770.
* Abbasi B, Shaw NM, Lui JL, Hakam N, Nabavizadeh B, Breyer BN. Oral phosphodiesterase type 5 inhibitors and priapism: A VigiBase analysis. Pharmacoepidemiol Drug Saf. 2024 Jan;33(1):e5721. doi: 10.1002/pds.5721. Epub 2023 Nov 1. PMID: 37909414.
* Webb AJS, Birks JS, Feakins KA, Lawson A, Dawson J, Rothman AMK, Werring DJ, Llwyd O, Stewart CR, Thomas J. Cerebrovascular Effects of Sildenafil in Small Vessel Disease: The OxHARP Trial. Circ Res. 2024 Jul 5;135(2):320-331. doi: 10.1161/CIRCRESAHA.124.324327. Epub 2024 Jun 4. PMID: 38832504; PMCID: PMC11227301.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.